Stacy L. Vezina

@Finepoint Capital Lp

Latest period2024 - Q3

Reported2mo 6d ago

Managed Assets$1.376B

Total holdings26

Assets growth rate290.61%

Assets growth rate (2-Q avg)140.48%

Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Finepoint Capital Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 26 positions.

Assets under management

The assets under management (AUM) of Finepoint Capital Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.376B in assets, with a quarterly growth rate of 290.61% and a 2-quarter average growth rate of 140.48%. The portfolio is managed by Stacy L. Vezina, and others.

Portfolio holdings

Current New Position Increased Decreased Exited

Investment	Portfolio %	Reported Value	Recent Activity
RVMDRevolution Medicines Inc Recent Activity Increased 0.35%	2.42%	$33.194M 731,960 shares@ $45.35 avg price	Increased 0.35%
ARGXArgenx Se Recent Activity Increased 0.75%	2.15%	$29.504M 54,428 shares@ $542.08 avg price	Increased 0.75%
ASNDAscendis Pharma A S Recent Activity Increased 0.43%	2.07%	$28.38M 190,072 shares@ $149.31 avg price	Increased 0.43%
TVTXTravere Therapeutics Inc Recent Activity Increased 0.32%	1.82%	$24.934M 1.782M shares@ $13.99 avg price	Increased 0.32%
SWTXSpringworks Therapeutics Inc Recent Activity Increased 1.96%	1.52%	$20.853M 650,852 shares@ $32.04 avg price	Increased 1.96%
SRPTSarepta Therapeutics Inc Recent Activity Increased 0.53%	1.22%	$16.677M 133,535 shares@ $124.89 avg price	Increased 0.53%
GLPGGalapagos Nv Recent Activity Increased 2.77%	1.17%	$16.058M 557,762 shares@ $28.8 avg price	Increased 2.77%
RLAYRelay Therapeutics Inc Recent Activity Increased 1.3%	0.84%	$11.513M 1.626M shares@ $7.09 avg price	Increased 1.3%